Glaucoma Treatments

Find Glaucoma Treatments

Generic Name

Timolol

Brand Names

Betimol, Istalol, Timolol GFS, Timoptic, Timoptic-XE

FDA approval date: June 08, 1990

Classification: beta-Adrenergic Blocker

Form: Tablet, Solution

What is Betimol (Timolol)?

Betimol ® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Early Feasibility Study to Evaluate the Safety and Efficacy of a New Timolol Sustained-Release Intraocular Implant (TimoD) in Participants With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) Undergoing Cataract Surgery

Enrollment Status: Recruiting

Publish Date: July 30, 2026

Intervention Type: Drug, Device

Study Phase: Phase 1/Phase 2

Summary: The goal of this clinical trial is to test a new method to deliver an approved medicine called Timolol in the eye of participants with glaucoma or ocular hypertension and requiring cataract surgery. The study is conducted in two stages. The first stage (Stage 1/Phase 1) is intended to study the safety of 3 different doses of the study medication (called TimoD implant). The second stage (Stage 2/Ph...

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris: A Comparative Study With Intense Pulsed Light (IPL)

Enrollment Status: Recruiting

Publish Date: April 01, 2026

Intervention Type: Drug, Device

Study Phase: Early Phase 1

Summary: Post-inflammatory erythema (PIE) is a common sequela of acne vulgaris, characterized by persistent erythematous macules resulting from superficial vascular dilation. Current treatment options include energy-based devices such as intense pulsed light (IPL); however, these modalities may be costly and require specialized equipment. Timolol, a non-selective beta-adrenergic receptor blocker, has demon...

Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Enrollment Status: Recruiting

Publish Date: March 30, 2026

Intervention Type: Procedure, Other, Drug

Study Phase: Phase 3

Summary: Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

View All Clinical Trials